COVID-19-Induced Actemra Shortage Causes Headaches For CAR-T Centers

Some Hematologists Report Having Problems Scheduling Cell Therapy

3D illustration of T cells attacking a cancer cell (CAR-T cell therapy) - Illustration
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip